The medtech company Kontigo Care reports small changes in revenue and earnings in the fourth quarter. Revenue amounted to SEK 7.6 million (7.6).The operating result was SEK -1.2 million (-0.6). Result after tax was SEK -1.2 million (-0.6). Earnings per share amounted to SEK -0.03 (-0.02). No ordinary dividend is proposed (0)."2025 has been a challenging but necessary year of transition for Kontigo Care. The continued strained economic situation in the municipal sector has affected demand and lengthened sales cycles, which is reflected in both revenue and license volumes. At the same time, during the year we have implemented several strategically important changes that strengthen the company’s long-term position," states CEO Alex Stendahl in the report. He emphasizes in the report that the company has moved from being a research and development company to a product company. "That we have won five of six public procurements during the year is a sign of strength. Although these have not yet fully impacted revenue, they represent a significant potential order value and strengthen our position with the municipalities - our most important customer group. Start-up with these customers began during the quarter, which is a prerequisite for increased use during 2026," states the Kontigo Care CEO. "In summary, we leave 2025 with a more stable cost base, a clearer offering and a business model that better supports scalable growth. Our focus going forward is on increased activation with existing customers, more platform agreements, and converting won procurements into actual usage and revenue," he continues. Kontigo Care, SEK millionQ4-2025Q4-2024ChangeNet sales7.67.60.0%Operating result-1.2-0.6Net income-1.2-0.6Earnings per share, SEK-0.03-0.02Ordinary annual dividend per share, SEK00